439 related articles for article (PubMed ID: 16215684)
1. Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: relation to drug cytotoxicity and caspase-3 activation.
Koceva-Chyła A; Jedrzejczak M; Skierski J; Kania K; Jóźwiak Z
Apoptosis; 2005 Dec; 10(6):1497-514. PubMed ID: 16215684
[TBL] [Abstract][Full Text] [Related]
2. Changes in plasma membrane fluidity of immortal rodent cells induced by anticancer drugs doxorubicin, aclarubicin and mitoxantrone.
Jedrzejczak M; Koceva-Chyła A; Gwoździński K; Jóźwiak Z
Cell Biol Int; 1999; 23(7):497-506. PubMed ID: 10728787
[TBL] [Abstract][Full Text] [Related]
3. Analysis of aclarubicin-induced cell death in human fibroblasts.
Kania K; Matławska-Wasowska K; Osiecka R; Jóźwiak Z
Cell Biol Int; 2007 Sep; 31(9):1049-56. PubMed ID: 17498978
[TBL] [Abstract][Full Text] [Related]
4. Aclarubicin-induced apoptosis and necrosis in cells derived from human solid tumours.
Rogalska A; Szwed M; Jóźwiak Z
Mutat Res; 2010 Jul; 700(1-2):1-10. PubMed ID: 20399885
[TBL] [Abstract][Full Text] [Related]
5. The effect of 3-(5-nitro-2-thienyl)-9-chloro-5-morpholin-4-yl[1,2,4]triazolo[4,3-c]quinazoline on cell growth, cell cycle, induction of DNA fragmentation, and activity of caspase 3 in murine leukemia L1210 cells and fibroblast NIH-3T3 cells.
Jantová S; Letasiová S; Repický A; Ovádeková R; Lakatos B
Cell Biochem Funct; 2006; 24(6):519-30. PubMed ID: 16342136
[TBL] [Abstract][Full Text] [Related]
6. Combined effect of low-power laser irradiation and anthraquinone anticancer drug aclarubicin on survival of immortalized cells: Comparison with mitoxantrone.
Koceva-Chyła A; Wiecławska B; Jóźwiak Z; Bryszewska M
Cell Biol Int; 2006 Aug; 30(8):645-52. PubMed ID: 16857396
[TBL] [Abstract][Full Text] [Related]
7. GP7 can induce apoptotic DNA fragmentation of human leukemia cells through caspase-3-dependent and -independent pathways.
Qi SN; Yoshida A; Wang ZR; Ueda T
Int J Mol Med; 2004 Jan; 13(1):163-7. PubMed ID: 14654989
[TBL] [Abstract][Full Text] [Related]
8. Caspase-3 activation during apoptosis caused by glutathione-doxorubicin conjugate.
Asakura T; Sawai T; Hashidume Y; Ohkawa Y; Yokoyama S; Ohkawa K
Br J Cancer; 1999 May; 80(5-6):711-5. PubMed ID: 10360648
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells.
Kluza J; Marchetti P; Gallego MA; Lancel S; Fournier C; Loyens A; Beauvillain JC; Bailly C
Oncogene; 2004 Sep; 23(42):7018-30. PubMed ID: 15273722
[TBL] [Abstract][Full Text] [Related]
10. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
[TBL] [Abstract][Full Text] [Related]
11. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
12. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
13. [In vivo antitumor activity of mitoxantrone and the flow cytometric analysis of its influence on cell cycle transition--comparison with doxorubicin and aclarubicin on ascitic hepatoma AH109A cells].
Asamura M; Yokoyama M; Kanamaru R; Kikuchi H; Gamoh M; Okuno M; Yi CD; Wakui A
Gan To Kagaku Ryoho; 1989 Dec; 16(12):3769-76. PubMed ID: 2596860
[TBL] [Abstract][Full Text] [Related]
14. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia.
Szmigielska-Kaplon A; Smolewski P; Najder M; Robak T
Ann Hematol; 2002 Sep; 81(9):508-13. PubMed ID: 12373351
[TBL] [Abstract][Full Text] [Related]
16. Plant-derived abrin-a induces apoptosis in cultured leukemic cell lines by different mechanisms.
Ohba H; Moriwaki S; Bakalova R; Yasuda S; Yamasaki N
Toxicol Appl Pharmacol; 2004 Mar; 195(2):182-93. PubMed ID: 14998684
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity of diacetoxyscirpenol is associated with apoptosis by activation of caspase-8 and interruption of cell cycle progression by down-regulation of cdk4 and cyclin B1 in human Jurkat T cells.
Jun DY; Kim JS; Park HS; Song WS; Bae YS; Kim YH
Toxicol Appl Pharmacol; 2007 Jul; 222(2):190-201. PubMed ID: 17559898
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide and peroxynitrite induce cellular death in bovine chromaffin cells: evidence for a mixed necrotic and apoptotic mechanism with caspases activation.
Vicente S; Pérez-Rodríguez R; Oliván AM; Martínez Palacián A; González MP; Oset-Gasque MJ
J Neurosci Res; 2006 Jul; 84(1):78-96. PubMed ID: 16625660
[TBL] [Abstract][Full Text] [Related]
19. Activation of caspases-3/7 is dispensable for idarubicin-induced apoptotic DNA fragmentation in human leukemia cells.
Qi SN; Yoshida A; Ueda T
Int J Oncol; 2003 May; 22(5):1123-8. PubMed ID: 12684680
[TBL] [Abstract][Full Text] [Related]
20. Indirubin-3-monooxime induced cell cycle arrest and apoptosis in Hep-2 human laryngeal carcinoma cells.
Kameswaran TR; Ramanibai R
Biomed Pharmacother; 2009 Feb; 63(2):146-54. PubMed ID: 18450412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
